1	Dr.	dr.	NNP	_	3	nn	_
2	Paolo	paolo	NNP	_	3	nn	_
3	Casali	casali	NNP	_	22	nsubj	22:A1=PPT
4	,	,	,	_	3	punct	_
5	with	with	IN	_	3	prep	_
6	the	the	DT	_	7	det	_
7	School	school	NNP	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	Medicine	medicine	NNP	_	8	pobj	_
10	at	at	IN	_	7	prep	_
11	the	the	DT	_	12	det	_
12	University	university	NNP	_	10	pobj	_
13	of	of	IN	_	12	prep	_
14	Texas	texas	NNP	_	17	nn	_
15	Health	health	NNP	_	17	nn	_
16	Science	science	NNP	_	17	nn	_
17	Center	center	NNP	_	13	pobj	_
18	at	at	IN	_	17	prep	_
19	San	san	NNP	_	20	nn	_
20	Antonio	antonio	NNP	_	18	pobj	_
21	,	,	,	_	22	punct	_
22	is	be	VBZ	pb=be.01	0	root	_
23	one	#crd#	CD	_	22	attr	22:A2=PRD
24	of	of	IN	_	23	prep	_
25	six	#crd#	CD	_	26	num	_
26	recipients	recipient	NNS	_	24	pobj	_
27	of	of	IN	_	26	prep	_
28	a	a	DT	_	29	det	_
29	grant	grant	NN	_	27	pobj	_
30	from	from	IN	_	29	prep	_
31	the	the	DT	_	32	det	_
32	Alliance	alliance	NNP	_	30	pobj	_
33	for	for	IN	_	32	prep	_
34	Lupus	lupus	NNP	_	35	nn	_
35	Research	research	NNP	_	33	pobj	_
36	.	.	.	_	22	punct	_

1	Casaliâ€™s	casaliâ€™s	``	p2=POS	11	punct	_
2	three	#crd#	CD	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	year	year	NN	_	11	npadvmod	_
5	,	,	,	_	11	punct	_
6	$	$	$	_	7	nmod	_
7	600,000	0	CD	_	8	nn	_
8	grant	grant	NN	p2=WDT	11	nsubjpass	13:A0=PAG;11:A1=PPT
9	will	will	MD	_	11	aux	11:AM-MOD
10	be	be	VB	_	11	auxpass	_
11	used	use	VBN	pb=use.01	0	root	_
12	to	to	TO	_	13	aux	_
13	study	study	VB	pb=study.01	11	xcomp	11:A2=PRP
14	the	the	DT	_	15	det	_
15	impact	impact	NN	_	13	dobj	13:A1=PPT
16	of	of	IN	_	15	prep	_
17	drugs	drug	NNS	_	16	pobj	18:A1=PPT
18	called	call	VBN	p2=VBD|pb=call.01	17	partmod	_
19	epigenetic	epigenetic	JJ	p2=NN	20	amod	_
20	modulators	modulator	NNS	_	18	oprd	18:A2=PRD
21	on	on	IN	_	20	prep	_
22	lupus	lupus	NNS	p2=NN	21	pobj	_
23	.	.	.	_	11	punct	_

1	Systemic	systemic	JJ	p2=NNP	2	amod	_
2	lupus	lupus	NNS	p2=NN	3	nsubj	3:A0
3	erythematosus	erythematosus	VBP	p2=NNS|pb=erythematosus.01	0	root	_
4	,	,	,	_	3	punct	_
5	SLE	sle	NNP	_	7	nsubj	7:A1=PPT
6	,	,	,	_	7	punct	_
7	is	be	VBZ	pb=be.01	0	root	_
8	an	an	DT	_	10	det	_
9	autoimmune	autoimmune	JJ	p2=NN	10	amod	_
10	disease	disease	NN	_	7	attr	12:A0=PAG;7:A2=PRD
11	that	that	WDT	p2=IN	12	nsubj	12:R-A0
12	debilitates	debilitate	VBZ	pb=debilitate.01	10	rcmod	_
13	as	as	RB	_	17	advmod	_
14	many	many	JJ	_	17	amod	_
15	as	as	IN	_	17	quantmod	_
16	1.5	0	CD	_	17	number	_
17	million	#crd#	CD	_	18	num	_
18	Americans	american	NNPS	_	19	nsubj	_
19	â€	â€	VBP	p2=,	12	dobj	_
20	"	"	``	p2=''	22	punct	_
21	mostly	mostly	RB	_	22	advmod	_
22	women	woman	NNS	_	12	dobj	12:A1=PPT;24:A1=PPT
23	who	who	WP	_	24	nsubj	24:R-A1
24	are	be	VBP	pb=be.01	22	rcmod	_
25	in	in	IN	_	24	prep	24:A2=PRD
26	their	their	PRP$	_	28	poss	_
27	fertile	fertile	JJ	_	28	amod	_
28	years	year	NNS	_	25	pobj	_
29	.	.	.	_	7	punct	_

1	Some	some	DT	_	2	det	_
2	scientists	scientist	NNS	_	3	nsubj	3:A0=PAG
3	believe	believe	VBP	pb=believe.01	0	root	_
4	that	that	IN	p2=WDT	17	complm	_
5	epigenetic	epigenetic	JJ	p2=NN	6	amod	_
6	modulators	modulator	NNS	_	17	nsubj	9:A1=PPT;17:A1=PPT
7	,	,	,	_	6	punct	_
8	often	often	RB	_	9	advmod	9:AM-TMP
9	used	use	VBN	pb=use.01	6	partmod	_
10	in	in	IN	_	9	prep	9:AM-LOC
11	the	the	DT	_	12	det	_
12	treatment	treatment	NN	_	10	pobj	_
13	of	of	IN	_	12	prep	_
14	lymphomas	lymphoma	NNS	p2=NN	13	pobj	_
15	,	,	,	_	17	punct	_
16	could	could	MD	_	17	aux	17:AM-MOD
17	be	be	VB	pb=be.01	3	ccomp	3:A1=PPT
18	useful	useful	JJ	_	19	amod	_
19	therapies	therapy	NNS	_	17	attr	17:A2=PRD
20	for	for	IN	p2=CC	19	prep	_
21	lupus	lupus	NNS	p2=NN	20	pobj	_
22	as	as	RB	_	23	advmod	_
23	well	well	RB	_	17	advmod	17:AM-ADV
24	.	.	.	_	3	punct	_

1	Casali	casali	NNP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	contributed	contribute	VBN	pb=contribute.01	0	root	_
4	to	to	IN	p2=TO	3	prep	3:A2=GOL
5	fundamental	fundamental	JJ	_	6	amod	_
6	understandings	understanding	NNS	_	4	pobj	_
7	about	about	IN	_	6	prep	_
8	immune	immune	JJ	_	10	amod	_
9	system	system	NN	_	10	nn	_
10	abnormalities	abnormality	NNS	_	7	pobj	12:A1=PPT
11	that	that	WDT	_	12	nsubj	12:R-A1
12	occur	occur	VBP	pb=occur.01	10	rcmod	_
13	in	in	IN	_	12	prep	12:AM-LOC
14	SLE	sle	NNP	_	13	pobj	_
15	.	.	.	_	3	punct	_

1	These	these	DT	_	2	det	_
2	findings	finding	NNS	_	3	nsubj	3:A0=PAG
3	provide	provide	VBP	pb=provide.01	0	root	_
4	a	a	DT	_	6	det	_
5	scientific	scientific	JJ	_	6	amod	_
6	rationale	rationale	NN	_	3	dobj	3:A1=PPT
7	for	for	IN	_	6	prep	_
8	why	why	WRB	_	12	advmod	12:R-AM-CAU
9	epigenetic	epigenetic	JJ	p2=NN	10	amod	_
10	modulators	modulator	NNS	_	12	nsubj	12:A1=PPT
11	might	might	MD	_	12	aux	12:AM-MOD
12	be	be	VB	pb=be.01	7	pcomp	_
13	effective	effective	JJ	_	12	acomp	12:A2=PRD
14	in	in	IN	_	13	prep	_
15	humans	human	NNS	_	14	pobj	_
16	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	Alliance	alliance	NNP	_	8	nsubj	8:A0=PAG
3	for	for	IN	_	2	prep	_
4	Lupus	lupus	NNP	p2=NNPS	5	nn	_
5	Research	research	NNP	_	6	nn	_
6	grant	grant	NN	_	3	pobj	_
7	will	will	MD	_	8	aux	8:AM-MOD
8	identify	identify	VB	pb=identify.01	0	root	_
9	novel	novel	JJ	p2=NN	10	amod	_
10	targets	target	NNS	_	8	dobj	8:A1=PPT
11	for	for	IN	_	10	prep	_
12	new	new	JJ	_	14	amod	_
13	lupus	lupus	NNS	p2=NN	14	nn	_
14	therapeutics	therapeutic	NNS	p2=RB	11	pobj	_
15	.	.	.	_	8	punct	_

1	â€œOur	â€œour	PRP$	p2=NNP	2	poss	_
2	team	team	NN	_	6	nsubj	6:A0=PAG
3	of	of	IN	_	2	prep	_
4	investigators	investigator	NNS	_	3	pobj	_
5	has	have	VBZ	_	6	aux	_
6	conducted	conduct	VBN	pb=conduct.01	25	ccomp	25:A1=PPT
7	basic	basic	JJ	_	9	amod	_
8	science	science	NN	_	9	nn	_
9	research	research	NN	_	6	dobj	12:A0=PAG;6:A1=PPT
10	that	that	WDT	_	12	nsubj	12:R-A0
11	has	have	VBZ	_	12	aux	_
12	found	find	VBN	pb=find.01	9	rcmod	_
13	an	an	DT	_	16	det	_
14	immediate	immediate	JJ	_	16	amod	_
15	translational	translational	JJ	p2=NN	16	amod	_
16	relevance	relevance	NN	_	12	dobj	12:A1=PPT
17	to	to	IN	_	12	prep	_
18	a	a	DT	_	19	det	_
19	disease	disease	NN	_	17	pobj	_
20	,	,	,	_	19	punct	_
21	lupus	lupus	NN	p2=NNS	19	conj	_
22	,	,	,	_	25	punct	_
23	â€�	â€�	NNP	p2=,	24	nn	_
24	Casali	casali	NNP	_	25	nsubj	25:A0
25	explains	explain	VBZ	pb=explain.01	0	root	_
26	.	.	.	_	25	punct	_

1	â€œFor	â€œfor	IN	p2=VB	25	prep	25:AM-TMP
2	the	the	DT	_	4	det	_
3	first	#ord#	JJ	_	4	amod	_
4	time	time	NN	_	1	pobj	_
5	,	,	,	_	25	punct	_
6	mechanisms	mechanism	NNS	_	25	nsubjpass	25:A1=PPT
7	important	important	JJ	_	6	amod	_
8	to	to	IN	_	7	prep	_
9	the	the	DT	_	10	det	_
10	generation	generation	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	autoantibodies	autoantibody	NNS	p2=FW	11	pobj	_
13	(	(	-LRB-	_	12	punct	_
14	the	the	DT	_	15	det	_
15	antibodies	antibody	NNS	_	12	appos	17:A0=PAG
16	that	that	WDT	p2=IN	17	nsubj	17:R-A0
17	attack	attack	VBP	pb=attack.01	15	rcmod	_
18	components	component	NNS	_	17	dobj	17:A1=PPT
19	of	of	IN	_	18	prep	_
20	the	the	DT	_	21	det	_
21	body	body	NN	_	19	pobj	_
22	)	)	-RRB-	p2=WDT	12	punct	_
23	have	have	VBP	_	25	aux	_
24	been	be	VBN	_	25	auxpass	_
25	identified	identify	VBN	pb=identify.01	0	root	_
26	.	.	.	_	25	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG;7:A0=PPT
2	outlined	outline	VBD	pb=outline.01	0	root	_
3	the	the	DT	_	4	det	_
4	mechanisms	mechanism	NNS	_	2	dobj	2:A1=PPT
5	and	and	CC	_	2	cc	_
6	then	then	RB	_	7	advmod	7:AM-TMP
7	looked	look	VBD	pb=look.01	2	conj	_
8	for	for	IN	_	7	prep	7:A1=GOL
9	drugs	drug	NNS	_	8	pobj	12:A0=PAG
10	that	that	WDT	_	12	nsubj	12:R-A0
11	may	may	MD	_	12	aux	12:AM-MOD
12	alter	alter	VB	pb=alter.01	9	rcmod	_
13	them	them	PRP	_	12	dobj	12:A1=PPT
14	.	.	.	_	2	punct	_

1	â€œWe	â€œwe	NNP	p2=PRP	4	nsubj	4:A0=PAG
2	will	will	MD	_	4	aux	4:AM-MOD
3	systematically	systematically	RB	_	4	advmod	4:AM-MNR
4	test	test	VB	pb=test.01	28	ccomp	28:A1=PPT
5	the	the	DT	_	6	det	_
6	ability	ability	NN	_	4	dobj	4:A1=LOC
7	of	of	IN	_	6	prep	_
8	different	different	JJ	_	10	amod	_
9	epigenetic	epigenetic	NN	p2=JJ	10	nn	_
10	modulators	modulator	NNS	_	7	pobj	_
11	to	to	TO	_	12	aux	_
12	blunt	blunt	VB	pb=blunt.01	6	infmod	_
13	the	the	DT	_	16	det	_
14	lupus	lupus	NNS	p2=JJ	15	nn	_
15	autoantibody	autoantibody	NN	p2=JJ	16	nn	_
16	response	response	NN	_	12	dobj	12:A1=PPT
17	and	and	CC	_	16	cc	_
18	prevent	prevent	VB	p2=NN|pb=prevent.01	16	conj	_
19	(	(	-LRB-	_	22	punct	_
20	or	or	CC	_	18	cc	_
21	)	)	-RRB-	_	22	punct	_
22	cure	cure	VB	p2=NN|pb=cure.01	18	conj	_
23	the	the	DT	_	24	det	_
24	disease	disease	NN	_	22	dobj	22:A2=PPT
25	,	,	,	_	28	punct	_
26	â€�	â€�	NNP	p2=''	27	nn	_
27	Casali	casali	NNP	_	28	nsubj	28:A0=PAG
28	adds	add	VBZ	pb=add.01	0	root	_
29	.	.	.	_	28	punct	_

1	The	the	DT	_	2	det	_
2	Alliance	alliance	NNP	_	7	nsubj	9:A0=PAG;7:A1=PAG
3	for	for	IN	_	2	prep	_
4	Lupus	lupus	NNP	_	5	nn	_
5	Research	research	NNP	p2=NN	6	nn	_
6	funding	funding	NN	_	3	pobj	_
7	complements	complement	VBZ	p2=NNS|pb=complement.01	0	root	_
8	and	and	CC	_	7	cc	_
9	expands	expand	VBZ	pb=expand.01	7	conj	_
10	the	the	DT	_	11	det	_
11	scope	scope	NN	_	9	dobj	9:A1=PPT
12	of	of	IN	_	11	prep	_
13	two	#crd#	CD	_	18	num	_
14	additional	additional	JJ	_	18	amod	_
15	and	and	CC	_	14	cc	_
16	larger	large	JJR	_	18	amod	_
17	National	national	NNP	_	18	nn	_
18	Institutes	institute	NNPS	p2=NNP	12	pobj	_
19	of	of	IN	_	18	prep	_
20	Health	health	NNP	_	21	nn	_
21	research	research	NN	_	22	nn	_
22	grants	grant	NNS	_	19	pobj	26:A1=PPT
23	Casali	casali	NNP	_	26	nsubj	26:A0=PAG
24	has	have	VBZ	_	26	aux	_
25	already	already	RB	_	26	advmod	26:AM-TMP
26	received	receive	VBN	pb=receive.01	22	rcmod	_
27	in	in	IN	_	26	prep	26:AM-LOC
28	support	support	NN	_	27	pobj	_
29	of	of	IN	_	28	prep	_
30	his	his	PRP$	_	31	poss	_
31	research	research	NN	_	29	pobj	_
32	.	.	.	_	7	punct	_

1	If	if	IN	_	4	mark	_
2	you	you	PRP	_	4	nsubj	4:A0=PAG;5:A0=PAG
3	are	be	VBP	_	4	aux	_
4	commenting	comment	VBG	pb=comment.01	15	advcl	15:AM-ADV
5	using	use	VBG	pb=use.01	4	xcomp	4:A1=PPT
6	a	a	DT	_	8	det	_
7	Facebook	facebook	NNP	p2=NN	8	nn	_
8	account	account	NN	_	5	dobj	5:A1=PPT
9	,	,	,	_	15	punct	_
10	your	your	PRP$	_	12	poss	_
11	profile	profile	NN	p2=JJ	12	nn	_
12	information	information	NN	_	15	nsubjpass	15:A1=PPT
13	may	may	MD	_	15	aux	15:AM-MOD
14	be	be	VB	_	15	auxpass	_
15	displayed	display	VBN	pb=display.01	0	root	_
16	with	with	IN	_	15	prep	15:A2=LOC
17	your	your	PRP$	_	18	poss	_
18	comment	comment	NN	_	16	pobj	19:A0=PAG
19	depending	depend	VBG	pb=depend.01	18	partmod	_
20	on	on	IN	_	19	prep	19:A1=PPT
21	your	your	PRP$	_	23	poss	_
22	privacy	privacy	NN	_	23	nn	_
23	settings	setting	NNS	_	20	pobj	_
24	.	.	.	_	15	punct	_

1	By	by	IN	_	16	prep	16:AM-MNR
2	leaving	leave	VBG	pb=leave.01	1	pcomp	_
3	the	the	DT	_	5	det	_
4	'	'	``	p2=''	5	punct	_
5	Post	post	NNP	p2=JJ	2	dobj	2:A1=DIR
6	to	to	IN	p2=TO	2	prep	2:A2=PRD
7	Facebook	facebook	NNP	_	9	poss	_
8	'	'	POS	p2=''	7	possessive	_
9	box	box	NN	_	6	pobj	10:A1=PPT
10	selected	select	VBD	p2=VBN|pb=select.01	9	partmod	_
11	,	,	,	_	16	punct	_
12	your	your	PRP$	_	13	poss	_
13	comment	comment	NN	_	16	nsubjpass	16:A1=PRD
14	will	will	MD	_	16	aux	16:AM-MOD
15	be	be	VB	_	16	auxpass	_
16	published	publish	VBN	pb=publish.01	0	root	_
17	to	to	IN	_	16	prep	16:AM-GOL
18	your	your	PRP$	_	20	poss	_
19	Facebook	facebook	NNP	p2=NN	20	nn	_
20	profile	profile	NN	p2=VB	17	pobj	_
21	in	in	IN	_	16	prep	16:AM-LOC
22	addition	addition	NN	_	21	pobj	_
23	to	to	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	space	space	NN	_	23	pobj	_
26	below	below	RB	_	25	advmod	_
27	.	.	.	_	16	punct	_

1	Sign	sign	VB	p2=VBN|pb=sign.03	0	root	_
2	up	up	RP	p2=IN	1	prt	1:C-V
3	to	to	TO	_	4	aux	_
4	receive	receive	VB	pb=receive.01	1	advcl	1:AM-PRP
5	San	san	NNP	_	7	nn	_
6	Antonio	antonio	NNP	_	7	nn	_
7	Business	business	NNP	_	8	nn	_
8	Journal	journal	NNP	_	11	poss	_
9	's	's	POS	_	8	possessive	_
10	Morning	morning	NNP	_	11	nn	_
11	Edition	edition	NNP	_	4	dobj	4:A1=PPT
12	and	and	CC	_	11	cc	_
13	Afternoon	afternoon	NNP	_	14	nn	_
14	Edition	edition	NNP	_	11	conj	_
15	newsletters	newsletter	NNS	_	11	appos	_
16	and	and	CC	_	1	cc	_
17	breaking	break	VBG	pb=break.01	1	conj	_
18	news	news	NN	_	19	nn	_
19	alerts	alert	NNS	_	17	dobj	17:A1=PPT
20	.	.	.	_	1	punct	_

